• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Kahn Swick & Foti

Kahn Swick & Foti represents investors in securities fraud class actions, as well as shareholders and consumers harmed by corporate wrongdoing.

  • About Us
    • About Our Firm
    • Institutional Investor Services
    • KSF in the Community
    • Careers at KSF
    • Contact Us
  • Attorneys
  • Practice Areas
    • Securities Class Action Litigation
    • Corporate Governance And Derivative Litigation
    • Consumer Protection Litigation
    • Shareholder Mergers and Acquisitions Class Action Litigation
    • Antitrust Litigation
  • Current Cases
  • KSF News
  • Client Login
  • Asset Recovery Services
  • Contact KSF

No Longer Accepting Claims In This Matter

Home»No Longer Accepting Claims In This Matter

Kahn Swick & Foti, LLC is no longer accepting claims in this matter. Please click here to see our current cases.

Primary Sidebar

Current Cases

Inovio Pharmaceuticals Inc. (NasdaqGS: INO)

Sorrento Therapeutics, Inc. (NasdaqGS: SRNE)

Nikola Corporation (NasdaqGS: NKLA, NKLAW) f/k/a VectoIQ Acquisition Corp. (NasdaqCM: VTIQ, VTIQW, VTIQU)

MultiPlan Corporation f/k/a Churchill Capital Corp. III (“Churchill”) (NYSE: MPLN)

Apache Corporation (NasdaqGS: APA)

CRH Medical Corporation (NYSE: CRHM)

see more»

KSF News

Notice of Settlement of Twitter, Inc. – Stockholder Derivative Litigation

$38 Million Proposed Settlement in Twitter Litigation

Preliminary Approval of Settlement in Health Insurance Innovations Litigation

see more»
 

Join Our Mailing List

To receive news of interest to shareholders and consumers and learn about potential new cases, you may join our mailing list by entering your email below.

Terms and Conditions | Privacy Notice

© 2006-2021 Copyright. All rights reserved Kahn Swick & Foti LLC · New Orleans · New York — Kahn Swick & Foti LLP · San Francisco